US$ 26.77
bpc-157 fda compounding category Regulatory Alert: The Legal Status of in and Clinical Practice – Holt Law FDA Peptide Update: Category 2
Description
CONTENTS OF THE PACK AND OTHER INFORMATION WHAT HYDROXOCOBALAMINE INJECTION CONTAINS The active substance is Hydroxocobalamin

Peptide bioavailability enhancer

Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL 33.3 mcg on a U-100 syringe
Knight SAB, Lesuisse E, Stearman R, Klausner RD, Dancis A

Those numbers got the entire peptide research community paying attention
